1. Home
  2. EYPT vs CCO Comparison

EYPT vs CCO Comparison

Compare EYPT & CCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

EYPT

EyePoint Pharmaceuticals Inc.

HOLD

Current Price

$13.35

Market Cap

1.3B

Sector

Industrials

ML Signal

HOLD

Logo Clear Channel Outdoor Holdings Inc.

CCO

Clear Channel Outdoor Holdings Inc.

HOLD

Current Price

$2.40

Market Cap

1.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
EYPT
CCO
Founded
1987
1995
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Laboratory Analytical Instruments
Advertising
Sector
Industrials
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.3B
1.2B
IPO Year
2005
2005

Fundamental Metrics

Financial Performance
Metric
EYPT
CCO
Price
$13.35
$2.40
Analyst Decision
Strong Buy
Hold
Analyst Count
5
5
Target Price
$31.80
$2.12
AVG Volume (30 Days)
724.3K
4.7M
Earning Date
05-06-2026
05-07-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
110.81
EPS
N/A
N/A
Revenue
$7,539,000.00
$1,604,140,000.00
Revenue This Year
N/A
$5.35
Revenue Next Year
$3,115.57
$4.26
P/E Ratio
N/A
N/A
Revenue Growth
N/A
6.57
52 Week Low
$5.57
$1.00
52 Week High
$19.11
$2.43

Technical Indicators

Market Signals
Indicator
EYPT
CCO
Relative Strength Index (RSI) 50.32 55.61
Support Level $12.66 $2.37
Resistance Level $13.32 $2.41
Average True Range (ATR) 0.74 0.01
MACD -0.03 0.00
Stochastic Oscillator 58.08 75.00

Price Performance

Historical Comparison
EYPT
CCO

About EYPT EyePoint Pharmaceuticals Inc.

EyePoint Inc focuses is a clinical-stage biopharmaceutical company committed to developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases, that may reduce the frequency of follow-up care. The company's pipeline program includes i) DURAVYU: a sustained-release product candidate for retinal diseases, with the potential to provide patients with improved visual outcomes with less burden. ii) EYP-2301: early-stage program using Durasert E technology to deliver razuprotafib, a TIE-2 agonist targeting VE-PTP for vascular stability in retinal diseases like wet AMD.

About CCO Clear Channel Outdoor Holdings Inc.

Clear Channel Outdoor Holdings Inc is a provider of out-of-home advertising solutions. The company offers advertisers an opportunity to reach mass audiences across various high-traffic public spaces, by using its diverse portfolio of assets including roadside billboards, street furniture, and airport displays. Its reportable segments are; America (U.S. operations excluding airports), Airports (U.S. and Caribbean airport operations), and Other. A majority of its revenue is generated from the America segment which generates revenue from the sale of advertising on printed and digital out-of-home advertising displays such as bulletins, posters, street furniture, and others. Geographically, the company generates maximum revenue from the United States followed by Singapore.

Share on Social Networks: